A new approach developed by researchers at University of California, Irvine, can vastly improve the targeting of chemotherapeutic drugs to specific cells and organs.
The findings of the study could pave the way to precisely targeted cancer treatments.
Chemotherapy
''Chemo'' means medicine or ''drug'', ''therapy'' means ''treatment''. Chemotherapy refers to the use of cytotoxic drugs in the treatment of cancer.
Advertisement
For the study, the researchers used liposomes, small spheres (less-than 100 nanometer in diameter) of naturally occurring lipid molecules, as "packages" for the cancer chemotherapeutic agent doxorubicin, and a small peptide molecule to "address" the package to the targeted tissue.
Using this technology, they showed that the doxorubicin was directed almost entirely to the targeted site with virtually no uptake by other organs, including lung, kidney and heart.
![Chemotherapy Drugs]( "Chemotherapy Drugs")
Chemotherapy drugs perform like 'magic bullets' to destroy cancer cells in the body.
The new approach is based on the fact that a dense region of sugar-containing molecules called polysaccharides surrounds all tissues and organs, including all tumors.
Most importantly, the particular chemical composition of the polysaccharides is different in each tissue and organ of the body.
The chemical compositions of the polysaccharides of tumour regions are also different from normal tissue.
The scientists developed a nanocarrier system that can recognize specific types of polysaccharide, and has demonstrated effective, organ-specific delivery of nanocarriers, and their therapeutic contents, based upon this polysaccharide-targeting approach.
In their study, the researchers used a peptide derived from a protein found in the microorganism Plasmodium, which has an exceptional ability to exclusively target the polysaccharides of liver following entry into the bloodstream.
The drug doxorubicin is a chemotherapeutic agent commonly used as treatment for a variety of cancers. When administered in a chemotherapeutic regimen, doxorubicin distributes widely in the body, including the heart, rather than specifically in tumor regions.
The serious heart damage that results from systemic administration places limits on the dosage that a patient can receive.
By encapsulating doxorubicin into a liposome package and including a peptide targeting message on the carrier, the researchers showed that doxorubicin can be effectively delivered to the liver, and away from the heart, with a specificity of greater than 100:1.
The study has appeared online in the International Journal of Pharmaceutics.
Source: ANI
SRM
Chemotherapy Drugs
Chemotherapy drugs perform like 'magic bullets' to destroy cancer cells in the body.
Advertisement
The new approach is based on the fact that a dense region of sugar-containing molecules called polysaccharides surrounds all tissues and organs, including all tumors.
Most importantly, the particular chemical composition of the polysaccharides is different in each tissue and organ of the body.
The chemical compositions of the polysaccharides of tumour regions are also different from normal tissue.
The scientists developed a nanocarrier system that can recognize specific types of polysaccharide, and has demonstrated effective, organ-specific delivery of nanocarriers, and their therapeutic contents, based upon this polysaccharide-targeting approach.
In their study, the researchers used a peptide derived from a protein found in the microorganism Plasmodium, which has an exceptional ability to exclusively target the polysaccharides of liver following entry into the bloodstream.
The drug doxorubicin is a chemotherapeutic agent commonly used as treatment for a variety of cancers. When administered in a chemotherapeutic regimen, doxorubicin distributes widely in the body, including the heart, rather than specifically in tumor regions.
The serious heart damage that results from systemic administration places limits on the dosage that a patient can receive.
By encapsulating doxorubicin into a liposome package and including a peptide targeting message on the carrier, the researchers showed that doxorubicin can be effectively delivered to the liver, and away from the heart, with a specificity of greater than 100:1.
The study has appeared online in the International Journal of Pharmaceutics.
Source: ANI
SRM
Researchers Show Inhibiting Action Of Enzyme That Makes Cancer Cells Sensitive To Chemotherapy
Researchers have for the first time shown that inhibiting the action of an enzyme called TAK-1 could make pancreatic cancer cells sensitive to chemotherapy.
Advertisement
 Sorafenib, Chemotherapy Combo Slow Breast Cancer ProgressionOne of the first of a series of trials to investigate the use of sorafenib - a targeted anti-cancer drug - for the treatment of advanced breast cancer... | Advertisement
|
Advertisement
Recommended Readings
Latest Research News
Trouble with sleep and the body's clock may increase your risk for Parkinson's, as per a new study.
New study uncovers a link between nocturnal hot flashes and Alzheimer's risk in menopausal women, suggesting a potential biomarker.
Our discovery revealed that a minority of individuals attributed their chronic pain to their brain's involvement.
Relative Energy Deficiency in Sport syndrome is overlooked by athletes and can be worsened by 'sports culture' due to its perceived short-term performance benefits.
New study sheds light on the intrinsic, yet often overlooked, role of sleep preparation as a hardwired survival strategy.
